deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT00186992

Radiation Therapy to Treat Musculoskeletal Tumors

Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects

Sponsor: Lance Armstrong Foundation

Updated 20 times since 2017 Last updated: Feb 18, 2026 Started: Jan 10, 2003 Primary completion: Sep 15, 2023 Completion: Oct 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00186992, this PHASE2 trial focuses on Musculoskeletal Tumors and Rhabdomyosarcoma and remains ongoing. Sponsored by Lance Armstrong Foundation, it has been updated 20 times since 2003, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Oct 2017 · 5 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Dec 2019 · 12 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Dec 2020 · 10 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~May 2022 · 12 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~May 2024 · 12 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshot~Apr 2025 – ~Mar 2026 · 11 months · monthly snapshot~Mar 2026 – present · 4 months · monthly snapshot

Change History

20 versions recorded
  1. Mar 2026 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Apr 2025 — Mar 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Dec 2024 — Apr 2025 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

Show 15 earlier versions
  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  2. May 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE2

  3. May 2022 — May 2023 [monthly]

    Active Not Recruiting PHASE2

  4. May 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE2

  5. Jan 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  7. Feb 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE2

  8. Dec 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE2

  9. Dec 2018 — Dec 2019 [monthly]

    Active Not Recruiting PHASE2

  10. Jun 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE2

  11. Dec 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  12. Oct 2017 — Dec 2017 [monthly]

    Active Not Recruiting PHASE2

  13. May 2017 — Oct 2017 [monthly]

    Active Not Recruiting PHASE2

  14. Feb 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE2

  15. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lance Armstrong Foundation
  • St. Jude Children's Research Hospital
Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations